UNSPSC 51362502: Cloperidone

This classification denotes a sedative and hypnotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8FP5Y6U39R. European Medicines Agency schedules Cloperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06738MIG. Cloperidone generally arises in the molecular formula C21H23CLN4O2.

UNSPSC 51362502 Cloperidone is a Commodity code for pharmaceutical products, though the recent state and local procurement activity under this code does not reflect cloperidone procurement. Seminole County, Florida's June 2026 IFB for naloxone and drug deactivation systems represents a mismatch with the code's nominal scope; the county is sourcing emergency-response pharmaceuticals and harm-reduction equipment rather than cloperidone, an antipsychotic medication. The code shows minimal relevant recent activity in the state and local market.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023 (a date inconsistency in the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. The solicitation requires electronic bid submission, includes all shipping and delivery costs in proposals, mandates drug-free workplace certification and E-Verify compliance, and carries a two-year initial term with an optional one-year renewal and a three-month probationary termination clause. The procurement notes potential FEMA funding with associated federal regulatory compliance requirements. No other recent state or local opportunities appear under this code. Given the absence of cloperidone-specific procurement signals and the single off-code opportunity, this Commodity code does not represent an active procurement avenue for state and local business development at this time.